Translating promising laboratory breakthroughs into effective therapies presents a formidable challenge. This complex journey is often plagued by obstacles, ranging from fundamental biological complexities to regulatory hurdles. Bridging this gap requires a multifaceted strategy that encompasses rigorous preclinical research, collaborative networks